Asthma, a chronic disease characterized by recurrent breathlessness and wheezing, continues to be a significant global health concern. As healthcare professionals, it is crucial to stay abreast of the latest advancements in its management. This article seeks to review some of the recent advances in asthma management.
Biologic therapies, designed to target specific molecules involved in the inflammatory process of asthma, have emerged as a promising approach. Monoclonal antibodies such as Omalizumab, Mepolizumab, and Benralizumab have shown efficacy in reducing exacerbation rates and improving quality of life, particularly in severe eosinophilic asthma.
Smart inhalers represent a technological advancement in asthma management. These devices can monitor usage, provide reminders, and share data with healthcare providers, thus enhancing medication adherence and facilitating personalized care.
Fractional exhaled nitric oxide (FeNO) testing is a non-invasive method to measure airway inflammation, which can help in diagnosing and monitoring asthma. It is particularly useful in identifying patients with eosinophilic inflammation who may benefit from corticosteroid therapy.
Bronchial thermoplasty, a novel therapeutic procedure, involves the delivery of thermal energy to the airway wall in a series of bronchoscopy procedures. It has been shown to reduce severe exacerbations and improve asthma control in patients with severe refractory asthma.
These advancements in asthma management are transforming care and improving patient outcomes. As healthcare professionals, our role is to integrate these new approaches into our practice, based on individual patient needs and characteristics. Continuous education and awareness of these developments will ensure that we provide the best possible care to our patients with asthma.
1.
Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety
2.
As EGFR internalization is decreased, BUB1 controls EGFR signaling.
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
Low Income, Education Tied to Depression in Older Adults
5.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
1.
Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care
2.
Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies
3.
Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine
4.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
5.
Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
4.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
5.
Navigating the Complexities of Ph Negative ALL - Part XV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation